| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Dec 4, 2024 | PTC THERAPEUTICS, INC. | Director | Sell | 10.0 | -24,000 | -21.89% | ✓ | $1.2M |
| Nov 20, 2024 | Nov 22, 2024 | NEXGEL, INC. | Director | Buy | 82.5 | +3,636 | 3.53% | ✗ | $10K |
| Aug 23, 2024 | Aug 27, 2024 | NEXGEL, INC. | Director | Buy | 91.3 | +10,000 | 10.75% | ✗ | $25K |
| May 22, 2024 | May 24, 2024 | PTC THERAPEUTICS, INC. | Director | Sell | 20.0 | -20,000 | -57.97% | ✗ | $764.8K |
| May 26, 2023 | May 30, 2023 | NEXGEL, INC. | Director | Buy | 86.3 | +5,000 | 5.68% | ✗ | $11.7K |
| Mar 25, 2022 | Mar 28, 2022 | NEXGEL, INC. | Director | Buy | 86.3 | +5,300 | 6.41% | ✗ | $10K |
| Dec 27, 2021 | Jan 3, 2022 | NEXGEL, INC. | Director | Buy | 91.3 | +9,091 | 12.35% | ✗ | $49.9K |
| May 14, 2021 | May 18, 2021 | SOLIGENIX, INC. | Director | Sell | 52.5 | - | 0.00% | ✗ | $36.6 |
| May 28, 2020 | May 28, 2020 | BioSig Technologies, Inc. | Director | Buy | 68.8 | +1,000 | 0.94% | ✗ | $10.5K |
| Nov 19, 2019 | Nov 19, 2019 | SOLIGENIX, INC. | Director | Buy | 85.0 | +2,000 | 9.56% | ✗ | $1.9K |
| Sep 19, 2019 | Sep 23, 2019 | SOLIGENIX, INC. | Director | Buy | 90.0 | +4,000 | 23.64% | ✗ | $3.7K |
| Apr 22, 2019 | Apr 22, 2019 | SOLIGENIX, INC. | Director | Buy | 90.0 | +10,000 | 144.57% | ✗ | $7.3K |
| Dec 23, 2015 | Dec 23, 2015 | SOLIGENIX, INC. | Director | Buy | 82.5 | +2,500 | 3.75% | ✗ | $3.2K |
| Jun 25, 2013 | Jun 26, 2013 | SOLIGENIX, INC. | Director | Buy | 91.3 | +23,809 | 95.24% | ✗ | $25K |